GTG.AX - Genetic Technologies Limited

ASX - ASX Delayed Price. Currency in AUD
0.0080
0.0000 (0.00%)
At close: 3:44PM AEDT
Stock chart is not supported by your current browser
Previous Close0.0080
Open0.0080
Bid0.008 x 0
Ask0.009 x 0
Day's Range0.0080 - 0.0080
52 Week Range0.0080 - 0.0210
Volume400,000
Avg. Volume8,940,658
Market Cap21.153M
Beta (3Y Monthly)1.82
PE Ratio (TTM)N/A
EPS (TTM)-0.002
Earnings DateMar 1, 2016 - Mar 5, 2016
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.25
  • GlobeNewswire3 months ago

    Genetic Technologies Invited to Establish a Market Presence in Hainan, China

    MELBOURNE, Australia, Sept. 17, 2018-- Hainan Resort Software Community has on behalf of Hainan Ecological Smart City Group formally extended an invitation to Genetic Technologies Limited to establish ...

  • ACCESSWIRE5 months ago

    Today’s Research Reports on Stocks to Watch: Genetic Technologies and Innovate Biopharmaceuticals

    NEW YORK, NY / ACCESSWIRE / July 17, 2018 / Genetic Technologies saw big gains on news that its breast cancer and colorectal cancer risk assessment tests are on track. Shares of Innovate were headed in the opposite direction on news that the company has filed a securities registration statement amendment with the SEC to issue up to $175 million of new stock and to sell 14 million shares of existing stock. Innovate Biopharmaceuticals, Inc.

  • Genetic Technologies Stock Up on Genetic Test Update
    Market Realist5 months ago

    Genetic Technologies Stock Up on Genetic Test Update

    Today, Genetic Technologies (GENE) was trading over 70% higher than yesterday’s closing price of $1.09. The stock jumped ~72.5% in premarket trading. The stock price and volumes rose on the news of the company’s on-track breast cancer and colorectal cancer risk assessment tests, slated for release in October.

  • Benzinga5 months ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Coda Octopus Group, Inc. (NASDAQ: CODA ) stock soared ...

  • PR Newswire9 months ago

    Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis

    NASDAQ: GENE) to accelerate the prediction of cancer for millions of individuals worldwide. GTG, whose lead product is BREVAGenplus® - a clinically validated risk assessment test for non-hereditary breast cancer - is at the forefront of preventive medicine.

  • Benzinga11 months ago

    Benzinga Pro's 5 Stocks To Watch Today

    Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Helios and Matheson Analytics Inc (NASDAQ: HMNY ) ...